Israel’s MigVax Receives $4.3M Award For Development Of Oral Vaccine
The funding is part of a $200 million CEPI program to advance the development of vaccines that provide protection against COVID-19 variants.
November 07, 2021
Israeli Oral COVID-19 Vaccine Booster Found Effective In Preclinical Trials
MigVax is ready to begin human clinical trials with its oral vaccine and is on track to market it as a booster in the next year.
June 15, 2021
OurCrowd Hosts 1st Pandemic Innovation Conference Focused On Investing In ‘New Normal’
The OurCrowd Pandemic Innovation Conference brought together thousands of top investors, entrepreneurs, VCs, executives, and officials from 90 countries.
June 22, 2020
Israeli Team Developing Coronavirus Vaccine Raises $12M For New Startup, To Begin Summer Trials
The new company, MigVax, is an affiliate of The Migal Galilee Research Institute and will pioneer the effort to develop the vaccine.
April 22, 2020
